Tafalgie Therapeutics

Marseille, France

Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research.

$14.1M raised

Sep 2025

Series A

Biopharma Biotechnology Health Care Medical

Top Investors

Bpifrance European Innovation Council EIC Accelerator Incubateur Impulse

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tafalgie Therapeutics

How much funding has Tafalgie Therapeutics raised?

Tafalgie Therapeutics has raised $14.1M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are Tafalgie Therapeutics's investors?

Tafalgie Therapeutics's investors include Bpifrance, European Innovation Council, EIC Accelerator, Incubateur Impulse.

Where is Tafalgie Therapeutics headquartered?

Tafalgie Therapeutics is headquartered in Marseille, France.

What does Tafalgie Therapeutics do?

Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research.

What stage is Tafalgie Therapeutics at?

Tafalgie Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 15, 2025.

MLA

"Tafalgie Therapeutics — Funding & Investors." VCBacked, September 15, 2025, https://www.vcbacked.co/company/tafalgie-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Tafalgie Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tafalgie-therapeutics

Wikipedia (cite web)

{{cite web |title=Tafalgie Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tafalgie-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 15, 2025.